Establishing cost-effectiveness of atypical neuroleptics

Editorial

G Robert et al. Br J Psychiatry. 1997 Aug.

. 1997 Aug:171:103-4.

doi: 10.1192/bjp.171.2.103.

No abstract available

Comment in

Establishing cost-effectiveness of antipsychotic drugs.
Taylor DM. Taylor DM. Br J Psychiatry. 1997 Nov;171:486. doi: 10.1192/bjp.171.5.486a. Br J Psychiatry. 1997. PMID: 9463618 No abstract available.
Establishing cost-effectiveness of antipsychotic drugs.
Adams CE. Adams CE. Br J Psychiatry. 1997 Nov;171:486. doi: 10.1192/bjp.171.5.486b. Br J Psychiatry. 1997. PMID: 9463619 No abstract available.
Cost-effectiveness of clozapine.
Kerwin RW, Aitchison KJ. Kerwin RW, et al. Br J Psychiatry. 1997 Dec;171:584. doi: 10.1192/bjp.171.6.584a. Br J Psychiatry. 1997. PMID: 9519106 No abstract available.

Cost-effectiveness of clozapine. A UK clinic-based study.
Aitchison KJ, Kerwin RW. Aitchison KJ, et al. Br J Psychiatry. 1997 Aug;171:125-30. doi: 10.1192/bjp.171.2.125. Br J Psychiatry. 1997. PMID: 9337946